Investment
Features
FeesSafety
Academy
More
Pluang+

Compare IQVIA Holdings Inc. Common Stock (IQV) vs Somnigroup International Inc. Common Stock (SGI) Price & Performance

IQVIA Holdings Inc. Common StockTrade
Somnigroup International Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

IQVIA Holdings Inc. Common Stock vs Somnigroup International Inc. Common Stock — how do they compare? IQVIA Holdings Inc. Common Stock trades at $261.7 (market cap $42.91B), while Somnigroup International Inc. Common Stock trades at $62.78 (market cap $14.48B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 3× Somnigroup International Inc. Common Stock's market cap, and Somnigroup International Inc. Common Stock pays a 1.08% dividend while IQVIA Holdings Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold IQVIA Holdings Inc. Common Stock for 6 Days and Somnigroup International Inc. Common Stock for 0 Days on average.

IQVSGI
Market Cap
$42.91B$14.48B
Volume
1,333,4561,734,399
Sector
HealthConsumer Cyclical
52-Week High
$275.02$97.99
52-Week Low
$156.66$61.49
Typical Hold Time
6 Days0 Days
Enterprise Value
$57.07B$20.78B
Dividend Yield
—1.08%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

IQVIA Holdings Inc. Common Stock

IQVIA Holdings (IQV) trades at $260.71, down 0.57% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $284.64. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $3.15 surpassing the $3.03 estimate. Revenue growth is steady, projected at $17.0B for 2026, while profitability metrics like a 23.01% ROE and 8.1% net income margin reflect operational strength. The company continues to innovate, launching new predictive analytics tools for life sciences clients.

The outlook for IQV remains positive, supported by strong earnings performance and analyst optimism, though investors should note valuation multiples above sector averages and debt levels. Key risks include competitive pressures in clinical research services and macroeconomic sensitivity affecting client spending.

Somnigroup International Inc. Common Stock

Somnigroup International (SGI) trades at $62.87, up 0.75% with neutral technical signals. The company shows strong profitability with 44.24% gross margins and has beaten earnings estimates for three consecutive quarters. Recent acquisition of Leggett & Platt enhances vertical integration with $75M synergy target. Analyst consensus is strongly bullish with 91% buy ratings and $94.50 price target, representing 50% upside potential from current levels.

SGI presents compelling growth prospects through strategic acquisitions and operational efficiencies, though faces margin pressures in weak bedding markets. The stock trades at reasonable valuations (P/E 24.85) with improving cash flow trends expected in 2026. Key risks include integration execution and market competition, but strong institutional interest and insider buying support the bullish case.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IQV

No sentiment data available yet.

SGI
100% Buy0% Sell
Avg holding period · 0 Days

About IQVIA Holdings Inc. Common Stock

IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.

Read more on IQV →

About Somnigroup International Inc. Common Stock

Somnigroup International Inc. (formerly Tempur Sealy International) is a bedding and sleep-products company that designs, manufactures, distributes, and retails mattresses and related products. It operates through Tempur Sealy North America, Tempur Sealy International, and Mattress Firm, with brands including Tempur-Pedic, Sealy, Stearns & Foster, and Mattress Firm.

Read more on SGI →